Shares of Fortis Healthcare gained 2.06% to trade at Rs 948.90 on Wednesday. The stock is a constituent of the Nifty Midcap 150 index.
On the financial front, Fortis Healthcare has demonstrated strong performance both on a quarterly and annual basis. The consolidated revenue for the quarter-ending June 2025 stood at Rs 2,166.72 Crore, up from Rs 1,858.90 Crore in June 2024. The net profit for the same period was Rs 263.86 Crore, compared to Rs 173.39 Crore in the previous year.
The annual consolidated revenue for the year-ending March 2025 reached Rs 7,782.75 Crore, a notable increase from Rs 6,892.92 Crore in March 2024. The net profit also saw an increase, rising to Rs 797.86 Crore in March 2025 from Rs 635.71 Crore in March 2024.
Key financial data is summarized below:
Financials (Consolidated) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|
Revenue (Rs Crore) | 4,030.12 | 5,717.61 | 6,297.63 | 6,892.92 | 7,782.75 |
Net Profit (Rs Crore) | -103.73 | 765.80 | 611.15 | 635.71 | 797.86 |
EPS | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 |
BVPS | 88.98 | 92.83 | 107.30 | 113.33 | 118.11 |
ROE | -1.79 | 8.98 | 8.12 | 7.81 | 8.68 |
Debt to Equity | 0.19 | 0.16 | 0.10 | 0.11 | 0.25 |
The company's revenue has shown consistent growth over the past five years. Revenue increased from Rs 4,030.12 Crore in 2021 to Rs 7,782.75 Crore in 2025. Net profit has also seen a positive trend, with a significant increase from a loss of Rs -103.73 Crore in 2021 to a profit of Rs 797.86 Crore in 2025.
Income Statement (Rs Crore) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|
Sales | 4,030 | 5,717 | 6,297 | 6,892 | 7,782 |
Other Income | 46 | 27 | 61 | 38 | 66 |
Total Income | 4,076 | 5,744 | 6,359 | 6,931 | 7,849 |
Total Expenditure | 3,915 | 4,634 | 5,438 | 5,951 | 6,669 |
EBIT | 161 | 1,110 | 920 | 979 | 1,179 |
Interest | 165 | 146 | 129 | 130 | 184 |
Tax | 99 | 197 | 180 | 212 | 197 |
Net Profit | -103 | 765 | 611 | 635 | 797 |
The sales for Fortis Healthcare have increased from Rs 4,030 Crore in March 2021 to Rs 7,782 Crore in March 2025. The net profit has also seen a significant turnaround, from a loss of Rs -103 Crore in March 2021 to a profit of Rs 797 Crore in March 2025.
Cash Flow (Rs Crore) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|
Operating Activities | 485 | 865 | 822 | 1,100 | 1,423 |
Investing Activities | -135 | -514 | -373 | -886 | -779 |
Financing Activities | -142 | -517 | -471 | -86 | -713 |
Others | 4 | 13 | 1 | -2 | 0 |
Net Cash Flow | 212 | -152 | -21 | 124 | -69 |
Cash flow from operating activities has generally increased over the years, from Rs 485 Crore in March 2021 to Rs 1,423 Crore in March 2025. However, investing and financing activities have generally resulted in cash outflows.
Balance Sheet (Rs Crore) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|
Share Capital | 754 | 754 | 754 | 754 | 754 |
Reserves & Surplus | 5,362 | 5,423 | 6,485 | 6,906 | 8,161 |
Current Liabilities | 1,233 | 1,269 | 1,425 | 3,170 | 1,607 |
Other Liabilities | 3,803 | 4,437 | 3,767 | 2,457 | 3,167 |
Total Liabilities | 11,154 | 11,884 | 12,433 | 13,288 | 13,691 |
Fixed Assets | 5,242 | 5,485 | 5,513 | 6,221 | 6,636 |
Current Assets | 1,036 | 1,133 | 1,406 | 1,420 | 1,471 |
Other Assets | 4,875 | 5,265 | 5,514 | 5,646 | 5,584 |
Total Assets | 11,154 | 11,884 | 12,433 | 13,288 | 13,691 |
Contingent Liabilities | 1,936 | 2,607 | 2,834 | 2,999 | 3,136 |
The total assets and total liabilities have generally increased over the years. Reserves and surplus have also shown a positive trend, increasing from Rs 5,362 Crore in March 2021 to Rs 8,161 Crore in March 2025.
Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|
Basic EPS (Rs.) | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 |
Diluted Eps (Rs.) | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 |
Book Value /Share (Rs.) | 88.98 | 92.83 | 107.30 | 113.33 | 118.11 |
Dividend/Share (Rs.) | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 |
Face Value | 10 | 10 | 10 | 10 | 10 |
Gross Profit Margin (%) | 11.19 | 19.17 | 18.46 | 18.94 | 21.26 |
Operating Margin (%) | 3.98 | 13.91 | 13.45 | 13.97 | 16.30 |
Net Profit Margin (%) | -2.57 | 13.39 | 9.70 | 9.22 | 10.25 |
Return on Networth / Equity (%) | -1.79 | 8.98 | 8.12 | 7.81 | 8.68 |
ROCE (%) | 1.61 | 7.49 | 7.69 | 9.52 | 10.50 |
Return On Assets (%) | -0.98 | 4.67 | 4.73 | 4.50 | 5.65 |
Current Ratio (X) | 0.84 | 0.89 | 0.99 | 0.45 | 0.92 |
Quick Ratio (X) | 0.78 | 0.80 | 0.90 | 0.41 | 0.84 |
Debt to Equity (x) | 0.19 | 0.16 | 0.10 | 0.11 | 0.25 |
Interest Coverage Ratios (X) | 0.97 | 7.47 | 9.01 | 9.97 | 8.97 |
Asset Turnover Ratio (%) | 36.12 | 0.08 | 0.09 | 0.54 | 0.58 |
Inventory Turnover Ratio (X) | 52.50 | 0.00 | 0.00 | 0.00 | 69.89 |
3 Yr CAGR Sales (%) | -6.00 | 13.11 | 16.60 | 30.78 | 16.67 |
3 Yr CAGR Net Profit (%) | -67.59 | 14.11 | 177.58 | 147.56 | 2.07 |
P/E (x) | -137.34 | 39.51 | 33.32 | 52.99 | 68.07 |
P/B (x) | 2.45 | 3.55 | 2.71 | 4.14 | 5.91 |
EV/EBITDA (x) | 36.26 | 21.26 | 17.90 | 25.16 | 33.04 |
P/S (x) | 3.73 | 3.83 | 3.12 | 4.60 | 6.78 |
Fortis Healthcare announced a final dividend of Rs 1.00 per share (10%) on May 20, 2025, with an effective date of July 25, 2025. The company had also announced final dividends of Rs 1.00 per share in the previous years.
Moneycontrol analysis indicates a very bullish sentiment for the stock.
With the stock currently trading at Rs 948.90, Fortis Healthcare has shown a positive trend in Wednesday's session, driven by strong financial performance and dividend announcements.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!